Anaplastic lymphoma kinase - Globe Thesis

Keyword [Anaplastic lymphoma kinase] Result: 21 - 40 \| Page: 2 of 3
21.	Molecular Dynamics Simulation Survey Of The Drug Resistance Mechanisms And Structural Activation Of ALK
22.	Clinical Efficacy,Survival Outcomes And Gene Profile Analysis Of Crizotinib In ALK-Positive Advanced Non-Small-Cell Lung Cancer
23.	Clinicoradiologic Features Associated With EGFR And ALK Gene Mutation In Lung Adenocarcinoma
24.	Relationship Between PD-L1 Expression And EGFR,ALK In Non-small Cell Lung Cancer And Its Clinical Significance
25.	Correlation Between EGFR And ALK Mutation And TTF-1 Expression In Lung Adenocarcinoma
26.	The Efficacy Of Crizotinib Versus Standard Chemotherapy In The Treatment Of Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer:A Meta-analysis
27.	The Study Of Overcoming Resistance Of Crizotinib By CT-707 And The Biomarkers Related To Tumorigenesis And Development Of Cancer
28.	Clinical Characteristics And Prognosis Analysis Of 71 Patients With ALK-positive Non-small Cell Lung Cancer
29.	Correlation Of HSP90?,ALK And EGFR Gene Mutations In Non-Small Cell Lung Cancer
30.	Heterogeneity Of Clinical Outcomes To Crizotinib In ALK-Rearranged Chinese Patients With Non-Small Cell Lung Cancer
31.	Efficacy And Safety Of First Line Treatments For Patients With Advanced Non-small-cell Lung Cancer Harboring ALK Gene Rearrangement:Network Meta-analysis
32.	Retrospective Analysis Of Epidemiological And Clinical Features Of Lung Cancer Driver Genes In Five Regions Of China
33.	A Study Of Early Resistance Of Crizotinib And Prognosis In Advanced Non-small Cell Lung Cancer Patients With ALK-fusion
34.	Clinical Efficacy Of Crizotinib Therapy In ALK-positive Advanced Non-small Cell Lung Cancer
35.	The Relationship Between The Expression Of TTF-1,Napsin A And EGFR,ALK Mutations And Clinical Features In Lung Adenocarcinoma
36.	Expression profiling and function elucidation of anaplastic lymphoma kinase in the developing nervous system
37.	Single chain antibody targeting of the ligand binding domain of the tyrosine kinase receptor anaplastic lymphoma kinase
38.	Understanding the function of the JunB transcription factor in anaplastic lymphoma kinase-positive, anaplastic large cell lymphoma
39.	New Clinical Strategies For Advanced Non-small Cell Lung Cancer
40.	The Value Of CT Radiomics Features In Predicting ALK Mutation And Distinguishing ALK Mutation From EGFR Mutation In Lung Adenocarcinoma
<<First <Prev Next> Last>> Jump to